Clinical Trial Update: A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating protective efficacy and safety of a recombinant herpes zoster vaccine is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant Herpes Zoster Vaccine

Snippet

Sponsor: Beijing Luzhu Biotechnology Co., Ltd. | Conditions: Vaccine-Preventable Diseases, Herpes Zoster | Phase 3 | Status: RECRUITING